- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical relevance of tumour-associated macrophages
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 19, Issue 6, Pages 402-421
Publisher
Springer Science and Business Media LLC
Online
2022-03-30
DOI
10.1038/s41571-022-00620-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
- (2021) Egle Ramelyte et al. CANCER CELL
- The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
- (2021) Anja Irmisch et al. CANCER CELL
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Liquid biopsy enters the clinic — implementation issues and future challenges
- (2021) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
- (2021) Moran Yang et al. Journal for ImmunoTherapy of Cancer
- Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
- (2021) David A. Braun et al. CANCER CELL
- Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
- (2021) Kevin Bi et al. CANCER CELL
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
- (2021) Sijin Cheng et al. CELL
- A gene–environment-induced epigenetic program initiates tumorigenesis
- (2021) Direna Alonso-Curbelo et al. NATURE
- CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
- (2021) Alba Rodriguez-Garcia et al. Nature Communications
- Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
- (2021) Chirag Krishna et al. CANCER CELL
- Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis
- (2021) Sabina Kaczanowska et al. CELL
- CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
- (2021) Sara Labiano et al. CLINICAL CANCER RESEARCH
- The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis
- (2021) Katja Niesel et al. EMBO Molecular Medicine
- Spatial tissue profiling by imaging-free molecular tomography
- (2021) Halima Hannah Schede et al. NATURE BIOTECHNOLOGY
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
- (2021) Ayse Bassez et al. NATURE MEDICINE
- Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
- (2021) Ana Rita Pombo Antunes et al. NATURE NEUROSCIENCE
- Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
- (2021) Christopher S. Garris et al. Science Translational Medicine
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
- (2021) Andrew X. Chen et al. Genome Medicine
- Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
- (2021) G. Emerens Wensink et al. npj Precision Oncology
- Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
- (2021) Mikyung Kang et al. ADVANCED MATERIALS
- Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
- (2021) Toshiro Hara et al. CANCER CELL
- Activating a collaborative innate-adaptive immune response to control metastasis
- (2021) Lijuan Sun et al. CANCER CELL
- The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
- (2021) Lexus R. Johnson et al. CELL
- Spatially organized multicellular immune hubs in human colorectal cancer
- (2021) Karin Pelka et al. CELL
- Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling
- (2021) Juhyun Oh et al. CLINICAL CANCER RESEARCH
- Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: Results from a phase I/II clinical trial
- (2021) Reetta Virtakoivu et al. CLINICAL CANCER RESEARCH
- Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
- (2021) Kevin Mulder et al. IMMUNITY
- Molecular architecture of the developing mouse brain
- (2021) Gioele La Manno et al. NATURE
- Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
- (2021) María Casanova-Acebes et al. NATURE
- Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis
- (2021) Roarke A. Kamber et al. NATURE
- Exploring tissue architecture using spatial transcriptomics
- (2021) Anjali Rao et al. NATURE
- A single-cell and spatially resolved atlas of human breast cancers
- (2021) Sunny Z. Wu et al. NATURE GENETICS
- An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
- (2021) Paula Voabil et al. NATURE MEDICINE
- An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples
- (2021) Roeltje R. Maas et al. Nature Protocols
- Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
- (2021) Rosalynd Upton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
- (2021) Sneha Berry et al. SCIENCE
- The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation
- (2021) Timothy D. Martin et al. SCIENCE
- Interpretation of T cell states from single-cell transcriptomics data using reference atlases
- (2021) Massimo Andreatta et al. Nature Communications
- Overcoming PD-1 Blockade Resistance With CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients With Metastatic Melanoma
- (2021) Antoni Ribas et al. Cancer Discovery
- Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
- (2021) Marie Siwicki et al. Science Immunology
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
- (2021) Joseph M. Chan et al. CANCER CELL
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
- (2021) Yuanyuan Zhang et al. CANCER CELL
- Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification
- (2021) Andrew M. Leader et al. CANCER CELL
- The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
- (2021) Hongzhong Li et al. CANCER CELL
- Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
- (2021) Khiem C. Lam et al. CELL
- In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
- (2021) Xiaoqing Wang et al. CELL
- Atlas of clinically distinct cell states and ecosystems across human solid tumors
- (2021) Bogdan A. Luca et al. CELL
- LYVE1+ macrophages of murine peritoneal mesothelium promote omentum-independent ovarian tumor growth
- (2021) Nan Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
- (2021) Baihao Zhang et al. NATURE
- Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity
- (2021) Giusy Di Conza et al. NATURE IMMUNOLOGY
- Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
- (2021) Christine N. Spencer et al. SCIENCE
- Versatile neutrophil functions in cancer
- (2021) Marie Siwicki et al. SEMINARS IN IMMUNOLOGY
- An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
- (2021) Bo Xu et al. Nature Communications
- Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
- (2021) Mikhail Binnewies et al. Cell Reports
- Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells
- (2021) Christina Pfirschke et al. Cancer Immunology Research
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
- (2020) David A Sallman et al. BLOOD
- A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.
- (2020) George A. Fisher et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-cell genomic approaches for developing the next generation of immunotherapies
- (2020) Ido Yofe et al. NATURE MEDICINE
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
- (2020) Ekaterina Friebel et al. CELL
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Lineage tracing meets single-cell omics: opportunities and challenges
- (2020) Daniel E. Wagner et al. NATURE REVIEWS GENETICS
- The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
- (2020) Janis M Taube et al. Journal for ImmunoTherapy of Cancer
- Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
- (2020) Andrew L. Ji et al. CELL
- The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
- (2020) Aleksandra Deczkowska et al. CELL
- Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer
- (2020) Yonatan Katzenelenbogen et al. CELL
- TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
- (2020) Martina Molgora et al. CELL
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients
- (2020) M. Burgess et al. ONCOGENE
- Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
- (2020) Leila Akkari et al. Science Translational Medicine
- Organoid Models of Tumor Immunology
- (2020) Kanako Yuki et al. TRENDS IN IMMUNOLOGY
- The CCL5/CCR5 Axis in Cancer Progression
- (2020) Donatella Aldinucci et al. Cancers
- Mouse–human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
- (2020) Hye Ryun Kim et al. BRITISH JOURNAL OF CANCER
- New technology on the horizon: Fast analytical screening technique FNA (FAST‐FNA) enables rapid, multiplex biomarker analysis in head and neck cancers
- (2020) Sara I. Pai et al. CANCER CYTOPATHOLOGY
- Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients
- (2020) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- Targeting MARCO and IL-37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function
- (2020) Linnéa La Fleur et al. CANCER RESEARCH
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
- (2020) Alison E. Ringel et al. CELL
- Distinct developmental pathways from blood monocytes generate human lung macrophage diversity
- (2020) Elza Evren et al. IMMUNITY
- Tumor-infiltrating dendritic cell states are conserved across solid human cancers
- (2020) Genevieve M. Gerhard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
- (2020) Mark H O'Hara et al. LANCET ONCOLOGY
- Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
- (2020) Silke Eisinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
- (2019) Sandra M. M. Irenaeus et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
- (2019) Denis Migliorini et al. NEURO-ONCOLOGY
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mast Cells: A Double-Edged Sword in Cancer
- (2019) Afshin Derakhshani et al. IMMUNOLOGY LETTERS
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
- (2019) Nicholas F. Kuhn et al. CANCER CELL
- Phase I Study of Emactuzumab Single Agent or in Combination with Paclitaxel in Patients with Advanced/Metastatic Solid Tumors Reveals Depletion of Immunosuppressive M2-like Macrophages
- (2019) C A Gomez-Roca et al. ANNALS OF ONCOLOGY
- Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
- (2019) Yongwoo David Seo et al. CLINICAL CANCER RESEARCH
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).
- (2019) Philippe Alexandre Cassier et al. JOURNAL OF CLINICAL ONCOLOGY
- Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
- (2019) Ignace Vergote et al. LANCET ONCOLOGY
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Cancer modeling meets human organoid technology
- (2019) David Tuveson et al. SCIENCE
- Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
- (2019) Keiro Shirotani et al. Scientific Reports
- Diversity, Mechanisms, and Significance of Macrophage Plasticity
- (2019) Massimo Locati et al. Annual Review of Pathology-Mechanisms of Disease
- Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
- (2019) Wenlong Zhang et al. BRITISH JOURNAL OF CANCER
- Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
- (2019) Ansuman T. Satpathy et al. NATURE BIOTECHNOLOGY
- Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
- (2019) Kaustav Bera et al. Nature Reviews Clinical Oncology
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
- (2019) Jing-Yiing Wu et al. MOLECULAR CELL
- Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program
- (2019) Laufey Geirsdottir et al. CELL
- Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
- (2019) Abhishek S. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
- (2018) Xuanmao Jiao et al. CANCER RESEARCH
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
- (2018) David Linehan et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab
- (2018) Ahmed T. Kurdi et al. MOLECULAR CANCER THERAPEUTICS
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
- (2018) Natalie J. Neubert et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Diverse Functions of Macrophages in Different Tumor Microenvironments
- (2018) Ming Yang et al. CANCER RESEARCH
- CXCR4 blockade at the end of irradiation to improve local control of glioblastoma (GBM).
- (2018) Reena Parada Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
- (2018) Juneko E. Grilley-Olson et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophages of distinct origins contribute to tumor development in the lung
- (2018) Pierre-Louis Loyher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
- (2018) Andreas Kuemmel et al. Scientific Reports
- Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting
- (2018) Merav Cohen et al. CELL
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- High expression of CCR5 in melanoma enhances epithelial-mesenchymal transition and metastasis via TGFβ1
- (2018) Jie Liu et al. JOURNAL OF PATHOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors
- (2018) Raffaella Fontana et al. OncoImmunology
- Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2017) David E. Cohn et al. GYNECOLOGIC ONCOLOGY
- Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
- (2017) Yu Zhu et al. IMMUNITY
- Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
- (2017) Jennifer L. Guerriero et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
- (2017) Miles A. Miller et al. Science Translational Medicine
- In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
- (2017) Sean P. Arlauckas et al. Science Translational Medicine
- CAR T Cells Releasing IL-18 Convert to T-Bet high FoxO1 low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
- (2017) Markus Chmielewski et al. Cell Reports
- Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
- (2016) Rony Dahan et al. CANCER CELL
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
- (2016) Niels Halama et al. CANCER CELL
- Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth
- (2016) Xiaolan Yu et al. CELL CYCLE
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions
- (2016) F. Pucci et al. SCIENCE
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
- (2016) Robert L. Bowman et al. Cell Reports
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
- (2015) Philippe A Cassier et al. LANCET ONCOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1
- (2015) Frank Szulzewsky et al. PLoS One
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- Development and function of human innate immune cells in a humanized mouse model
- (2014) Anthony Rongvaux et al. NATURE BIOTECHNOLOGY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- (2013) Felix Klug et al. CANCER CELL
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
- (2013) Y. Kienast et al. CLINICAL CANCER RESEARCH
- Angiotensin II Drives the Production of Tumor-Promoting Macrophages
- (2013) Virna Cortez-Retamozo et al. IMMUNITY
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma
- (2012) Juan Wu et al. CANCER RESEARCH
- Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice
- (2012) Amit Maliar et al. GASTROENTEROLOGY
- Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN- and GM-CSF
- (2012) P. Spear et al. JOURNAL OF IMMUNOLOGY
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Origins of tumor-associated macrophages and neutrophils
- (2012) V. Cortez-Retamozo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- The significant role of mast cells in cancer
- (2011) Khashayarsha Khazaie et al. CANCER AND METASTASIS REVIEWS
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis: Figure 1.
- (2011) Michele De Palma et al. CLINICAL CANCER RESEARCH
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
- (2010) K. Movahedi et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started